Status:
UNKNOWN
Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema
Lead Sponsor:
Rabin Medical Center
Conditions:
Corneal Edema
Visual Acuity
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Most patients undergoing cataract surgery suffer from corneal edema after the surgery. Brimonidine drops are a well known and safe Anti-glaucoma medication. the investigators have made several clinic...
Detailed Description
Most patients undergoing cataract surgery suffer from corneal edema after the surgery which temporarily reduces their visual acuity until corneal edema resolves over several weeks Brimonidine drops ar...
Eligibility Criteria
Inclusion
- 1 day after uneventful cataract surgery
- corneal edema (grade 2 to 3)
Exclusion
- glaucoma
- higher than normal intraocular pressure (\>23 mm Hg)
- known sensitivity or contra indication to brimonidine
- known sensitivity or contra indication to timolol
- pre operative corneal or anterior segment disease
- intraoperative complications
- major ocular pathology other than corneal that reduced vision (retinal degeneration, optic neuropathy etc.)
- pregnant women
- children
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00800423
Start Date
January 1 2009
End Date
January 1 2010
Last Update
December 2 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin medical center ophthalmology deparment
Petah Tikva, Israel, 49100